Aura Biosciences, Inc. 8-K

What Happened

• Aura Biosciences, Inc. (AURA) filed an 8-K reporting results of its June 11, 2026 Annual Meeting of Stockholders. Two director nominees were elected to the Board as Class II directors and Ernst & Young LLP was ratified as the company’s independent registered public accounting firm for fiscal 2026.
• Voting details: 64,199,778 shares were entitled to vote and 52,784,744 shares were present or represented by proxy (≈82.2% turnout). David Johnson was elected with 34,542,193 votes for, 6,628,297 votes withheld, and 11,614,254 broker non-votes. Teresa Marie Bitetti was elected with 40,526,332 votes for, 644,158 votes withheld, and 11,614,254 broker non-votes. The audit firm ratification received 52,752,601 votes for, 17,348 against, and 14,795 abstentions (zero broker non-votes).

Key Details

• Annual Meeting date: June 11, 2026.
• Shares entitled to vote: 64,199,778; shares represented: 52,784,744 (~82.2%).
• Director election results:
  • David Johnson: 34,542,193 for; 6,628,297 withheld; 11,614,254 broker non-votes.
  • Teresa Marie Bitetti: 40,526,332 for; 644,158 withheld; 11,614,254 broker non-votes.
• Auditor ratification: Ernst & Young LLP ratified (52,752,601 for; 17,348 against; 14,795 abstain).

Why It Matters

• Board composition and governance: The election results confirm the two nominees will serve as Class II directors through the 2029 annual meeting, shaping board oversight and strategy continuity. The differing vote totals show varying levels of shareholder support for each nominee.
• Audit continuity: Ratifying Ernst & Young LLP means the company will continue with that independent auditor for the 2026 fiscal year, an item investors watch for audit quality and reporting continuity.
• Shareholder engagement: With roughly 82% of shares represented, the meeting had strong participation; the presence of broker non-votes on director elections indicates some shares were held by brokers who did not have voting instructions from beneficial owners.

Filed and signed by Natalie Holles, Chief Executive Officer, on June 11, 2026.